Founded by Genzyme Alumni, Cambridge's X4 Pharma Scores $27M
X4 Pharma announced it had closed a $27M Series B financing. Source: BioSpace
Philadelphia Biotech Startup Context Therapeutics Names a New CFO, Effective Immediately
The company is strengthening its team as it transitions to a clinical development stage company. Source: BioSpace
All Systems Go: Johnson & Johnson Reaches Out for Second Ionis GI Drug
Ionis Pharma and Janssen have strengthened their alliance with a second deal for gastrointestinal drugs. Source: BioSpace
Don't Stop Believing: Teva's R&D Head Gives 3 Reasons Why Investors Should Hold On
Teva's stock jumped as investors get more hopeful about the future. Source: BioSpace
Astrazeneca Gets Another Boost With FDA Approval of Severe Asthma Drug
The drug, in combination with abemaciclib, showed 16.4 Months of progression-free survival. Source: BioSpace
San Diego's Mirati Therapeutics Abandons Lead Drug, Shifts Focus
Two months after positive preliminary data showed sitravatinib in combination with Opdivo demonstrated some efficacy in treating patients with NSCLC, Mirati said it will reprioritize its R&D to focus. Source:…
Meet the 5 Bay Area Biotech Entrepreneurs Under 30
Every year, Forbes creates lists of "30 Under 30" leaders in various industries who are under the age of 30. Source: BioSpace
Amgen's Repatha Reduces Cardiovascular Events in Patients with a History of Heart Attacks
Data from Amgen's Fourier study supports the use of Repatha to reduce the risk of recurrent cardiovascular events in patients with a history of multiple heart attacks. Source: BioSpace
Genentech Dumps Another $650M in New Haven Biotech Arvinas
Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace
How We Talk about Science and Science Denial
We write about science every day, why isn’t it getting through to the public consciousness? Source: BioSpace
- Go to the previous page
- 1
- …
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- …
- 288
- Go to the next page